Elevance Health
1,073 hedge funds and large institutions have $65.2B invested in Elevance Health in 2019 Q1 according to their latest regulatory filings, with 133 funds opening new positions, 352 increasing their positions, 433 reducing their positions, and 63 closing their positions.
111% more first-time investments, than exits
New positions opened: 133 | Existing positions closed: 63
19% more call options, than puts
Call options by funds: $395M | Put options by funds: $332M
8% more funds holding
Funds holding: 995 → 1,073 (+78)
0.06% more ownership
Funds ownership: 88.44% → 88.5% (+0.06%)
10% less capital inflows, than outflows
Capital inflows: $4.38B | Capital outflows: $4.86B
10% less funds holding in top 10
Funds holding in top 10: 51 → 46 (-5)
19% less repeat investments, than reductions
Existing positions increased: 352 | Existing positions reduced: 433
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$619M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$427M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$317M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$161M |
| 5 |
Goldman Sachs
New York
|
+$130M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$409M |
| 2 |
Lyrical Asset Management
New York
|
-$400M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$262M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
-$246M |
| 5 |
First Eagle Investment Management
New York
|
-$180M |
ELV Hedge Fund Activity: Q1 2019 in Review
1,073 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q1 2019, worth a combined $65.2B — up 8.6% from $60.1B a quarter earlier.
Buyers outnumbered sellers: 133 funds opened new ELV positions and 63 closed out — a net gain of 70 holders — while 352 added to existing stakes and 433 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $619M. The largest seller was BlackRock, cutting an estimated $409M.
- 1,073 institutional investors held Elevance Health (ELV) as of Q1 2019, up from 995 in Q4 2018.
- Funds reported $65.2B of Elevance Health stock for Q1 2019, up 8.6% quarter-over-quarter.
- 133 funds opened new Elevance Health positions in Q1 2019 and 63 closed out, a net change of +70 holders.
- The largest Elevance Health buyer in Q1 2019 was Wellington Management Group, an estimated $619M added.
- The largest Elevance Health seller in Q1 2019 was BlackRock, an estimated $409M sold.
Based on aggregated 13F filings for Q1 2019.